article

1. Rotating Palliative Care Patients From Full Agonist Opioids to Low Dose Milligram Buprenorphine..  Journal of pain and symptom management.  68:e156-e158. 2024
2. Treatment of Opioid Use Disorder in the General Hospital..  The American journal of psychiatry.  180:594-596. 2023
3. Pharmacologic Management of Cancer-Related Pain in Pregnant Patients..  Drugs.  83:1067-1076. 2023
4. Validation of ICD-9 Codes for Identification of Chronic Overlapping Pain Conditions..  Journal of pain & palliative care pharmacotherapy.  36:166-177. 2022
5. Impact of NCCN Guideline Adherence in Adult Cancer Pain on Length of Stay..  Journal of pain & palliative care pharmacotherapy.  36:95-102. 2022
6. Estimation of the Prevalence of Delayed Dispensing Among Opioid Prescriptions From US Surgeons and Dentists..  JAMA network open.  5:-. 2022
7. Risk Factors for the Development of Neuropsychiatric Adverse Effects in Ketamine-Treated Pain..  Journal of pain & palliative care pharmacotherapy.  36:1-7. 2022
8. The Efficacy of Capsaicin on Sleep Quality and Fatigue in Fibromyalgia..  Journal of pain & palliative care pharmacotherapy.  36:1-116. 2022
9. Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review..  Pharmacotherapy.  42:411-427. 2022
10. A Survey on Opioid Tapering Practices, Policies, and Perspectives by Pain and Palliative Care Pharmacists..  Journal of pain & palliative care pharmacotherapy.  36:2-10. 2022
11. Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder..  Pediatric blood & cancer.  69:-. 2021
12. Pharmacogenetics of Methadone for Pain Management in Palliative Care..  Journal of pain and symptom management.  63:e142-e145. 2021
13. Buprenorphine for Chronic Pain in a Pediatric Patient With Sickle-Cell Disease..  Journal of pain and symptom management.  62:1086-1091. 2021
14. Strategies for Rotation between Gabapentinoids in the Inpatient Setting..  Journal of pain & palliative care pharmacotherapy.  35:13-22. 2021
15. Rapid Buprenorphine Induction for Cancer Pain in Pregnancy..  Journal of palliative medicine.  24:1257-1262. 2020
16. Improving the Interdisciplinary Clinical Education of a Palliative Care Program through Quality Improvement Initiatives..  Palliative medicine reports.  1:270-279. 2020
17. Impact of a problem-based learning elective on performance in non-problem-based learning required courses..  Currents in pharmacy teaching & learning.  12:1470-1476. 2020
18. Acetaminophen in Patients Receiving Strong Opioids for Cancer Pain..  Journal of pain & palliative care pharmacotherapy.  34:197-202. 2020
19. Sublingual Buprenorphine for Pediatric Cancer Pain: A Case Report and Review of the Literature..  Journal of pain and symptom management.  60:1055-1058. 2020
20. A physician-pharmacist collaborative care model to prevent opioid misuse..  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.  77:771-780. 2020
21. Efficacy of acupressure for chronic low back pain: A systematic review..  Complementary therapies in clinical practice.  -. 2020
22. The Impact of Palliative Care Interventions on Medication Regimen Complexity..  Journal of palliative medicine.  23:156-157. 2020
23. Approaches to Medication Management in Patients with Kidney Failure Opting for Conservative Management..  Nephrology nursing journal : journal of the American Nephrology Nurses' Association.  47:319-371. 2020
24. Evaluation Tools for Interdisciplinary Palliative Care Learning Experiences: A Literature Review..  Journal of palliative medicine.  23:698-702. 2019
25. Comparing Methadone Rotation to Consensus Opinion..  Journal of pain and symptom management.  59:116-120. 2019
26. Differences in Adverse Effect Profiles of Corticosteroids in Palliative Care Patients..  The American journal of hospice & palliative care.  36:158-168. 2018
27. Using the Plan-Do-Study-Act (PDSA) Model for Continuous Quality Improvement of an Established Simulated Patient Program..  Innovations in pharmacy.  9:1-6. 2018
28. Using the LACE Score as a Predictor of Clinical Outcomes in Patients Referred for Inpatient Palliative Care Consultation: A Single-Center Experience..  The American journal of hospice & palliative care.  -. 2018
29. Provider Perspectives on Topical Analgesics..  Journal of pain & palliative care pharmacotherapy.  32:44-48. 2018
30. Management of Ischemic Limb Pain #352..  Journal of palliative medicine.  21:720-721. 2018
31. Review of Opioid Pharmacogenetics and Considerations for Pain Management..  Pharmacotherapy.  37:1105-1121. 2017
32. Transplant Medication Management for Patients Nearing End of Life #333..  Journal of palliative medicine.  20:895-896. 2017
33. Utilization of a virtual patient for advanced assessment of student performance in pain management..  Currents in pharmacy teaching & learning.  9:893-897. 2017
34. Symptom burden in heart failure: assessment, impact on outcomes, and management..  Heart failure reviews.  22:25-39. 2017
35. Virtual Patient Case Sharing Across Two Schools of Pharmacy..  American journal of pharmaceutical education.  80:-. 2016
36. Profile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infection..  Drug design, development and therapy.  6083-94. 2015
37. Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection..  The Annals of pharmacotherapy.  50:39-46. 2015
38. The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy..  Expert opinion on drug safety.  14:1649-52. 2015
39. Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection..  The Lancet. Infectious diseases.  15:993-995. 2015
40. Effectiveness of educational technology to improve patient care in pharmacy curricula..  American journal of pharmaceutical education.  79:-. 2015
41. Ledipasvir-sofosbuvir: interferon-/ribavirin-free regimen for chronic hepatitis C virus infection..  The Annals of pharmacotherapy.  49:343-50. 2014
42. Vedolizumab: an α4β7 integrin inhibitor for inflammatory bowel diseases..  The Annals of pharmacotherapy.  48:1629-35. 2014
43. Use of virtual patients in an advanced therapeutics pharmacy course to promote active, patient-centered learning..  American journal of pharmaceutical education.  78:-. 2014
44. Incidence and Management of Rash in Telaprevir-Treated Patients..  The Annals of pharmacotherapy.  48:1166-1171. 2014
45. Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients..  The Annals of pharmacotherapy.  48:77-85. 2013